IPSEN – Buy-back programme – Art 5 of MAR – Week 27- 2026
Aggregated presentation by day and by market
| Weekly report on share repurchases from 30th June to 03rd July 2026 | ||||||
| Name of the Issuer | Identify code of the Issuer | Transaction day | Identify code of the financial instrument | Total daily volume (in number of shares) | Daily weighted average purchase price of the shares | Market (MIC Code) |
| IPSEN | 549300M6SGDPB4Z94P11 | 30/06/2026 | FR0010259150 | 5 363 | 166,3622 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 02/07/2026 | FR0010259150 | 2 437 | 166,4798 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 03/07/2026 | FR0010259150 | 2 959 | 169,3556 | XPAR |
| TOTAL | 10 759 | 167,2121 | ||||
Attachment

IPSEN – Buy-back programme – Art 5 of MAR – Week 27- 2026
Aggregated presentation by day and by market
| Weekly report on share repurchases from 30th June to 03rd July 2026 | ||||||
| Name of the Issuer | Identify code of the Issuer | Transaction day | Identify code of the financial instrument | Total daily volume (in number of shares) | Daily weighted average purchase price of the shares | Market (MIC Code) |
| IPSEN | 549300M6SGDPB4Z94P11 | 30/06/2026 | FR0010259150 | 5 363 | 166,3622 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 02/07/2026 | FR0010259150 | 2 437 | 166,4798 | XPAR |
| IPSEN | 549300M6SGDPB4Z94P11 | 03/07/2026 | FR0010259150 | 2 959 | 169,3556 | XPAR |
| TOTAL | 10 759 | 167,2121 | ||||
Attachment

Related Press Releases
17 August 2026
IPSEN – Buy-back programme – Art 5 of MAR –...
10 August 2026
IPSEN – Buy-back programme – Art 5 of MAR –...
03 August 2026
IPSEN – Buy-back programme – Art 5 of MAR –...
30 July 2026
Ipsen S.A. publishes its 2026 Half-Year Report (half-year ended 30...
29 July 2026
Ipsen nominates Catherine Bradley to its Board of Directors as...
27 July 2026
IPSEN – Buy-back programme – Art 5 of MAR –...
24 July 2026
Ipsen provides update on Phase III BOLD trial in biliary...
22 July 2026
Ipsen – Corrective statement amending the monthly disclosure of the...
22 July 2026
Ipsen completes acquisition of Memo Therapeutics AG, adding first-in-class asset...
21 July 2026
IPSEN – Buy-back programme – Art 5 of MAR –...